ARCHIVES

Genentech: ODAC Lacks Expertise, Impartiality; FDA: Company’s Proposal Unscientific

This article is from The Cancer Letter archive.

Vol. 37 No. 32 | August 12, 2011

Download PDF Visit The Full Archive

Related Articles

DCT Board Committee Recommends Limited Start On In Vitro Screening Program

January 18, 1985

Beefed Up Centers Subcommittee Meets On Core Guidelines

December 2, 1977

NCI Resources, Services Available For Cancer Research

June 7, 1996

Cancer Death Rates Improving, But Still Higher, In Blacks

February 23, 2007

In the States: Michigan to Allocate $50 Million Annually To Life Sciences

July 23, 1999

Guest Editorial: Nobel Laureates Offer Simple Formula To Save CPRIT From “Infamy and Irrelevance”

October 19, 2012